Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients.

Poprach, Alexandr; Fiala, Ondrej; Chloupkova, Renata; Melichar, Bohuslav; Lakomy, Radek; Petrakova, Katarina; Zemanova, Milada; Kopeckova, Katerina; Slaby, Ondrej; Studentova, Hana; Kopecký, Jindrich; Kiss, Igor; Finek, Jindrich; Dusek, Ladislav; Buchler, Tomas

Poprach, Alexandr; Fiala, Ondrej; Chloupkova, Renata; Melichar, Bohuslav; Lakomy, Radek; Petrakova, Katarina; Zemanova, Milada; Kopeckova, Katerina; Slaby, Ondrej; Studentova, Hana; Kopecký, Jindrich; Kiss, Igor; Finek, Jindrich; Dusek, Ladislav; Buchler, Tomas.

Afiliación

Poprach A; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Fiala O; Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
Chloupkova R; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Pilsen, Czech Republic.
Melichar B; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Lakomy R; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Petrakova K; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
Zemanova M; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Kopeckova K; Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
Slaby O; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Studentova H; Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
Kopecký J; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Kiss I; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Finek J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Dusek L; Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
Buchler T; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.

Anticancer Res ; 38(1): 449-456, 2018 01.

Article en En | MEDLINE | ID: mdl-29277808

Asunto(s)

Inhibidores de la Angiogénesis/uso terapéutico; Carcinoma de Células Renales/tratamiento farmacológico; Neoplasias Renales/tratamiento farmacológico; Pirimidinas/uso terapéutico; Sulfonamidas/uso terapéutico; Adulto; Anciano; Anciano de 80 o más Años; Inhibidores de la Angiogénesis/efectos adversos; Carcinoma de Células Renales/patología; Carcinoma de Células Renales/cirugía; República Checa; Bases de Datos Factuales; Supervivencia sin Enfermedad; Femenino; Humanos; Indazoles; Indoles/uso terapéutico; Neoplasias Renales/patología; Neoplasias Renales/cirugía; Masculino; Persona de Mediana Edad; Nefrectomía; Proteínas Proto-Oncogénicas c-kit/antagonistas & inhibidores; Pirimidinas/efectos adversos; Pirroles/uso terapéutico; Receptores del Factor de Crecimiento Derivado de Plaquetas/antagonistas & inhibidores; Receptores de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores; Sistema de Registros; Estudios Retrospectivos; Sulfonamidas/efectos adversos; Sunitinib; Resultado del Tratamiento

Palabras clave

Renal cell carcinoma; cancer registry; pazopanib; response; survival

Buscar en Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renales / Inhibidores de la Angiogénesis / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Anticancer Res Año: 2018 Tipo del documento: Article País de afiliación: República Checa

Buscar en Google

Imprimir

XML

PubMed Links